PCG
NVAX icon

Private Capital Group’s Novavax NVAX Stock Holding History

Private Capital Group’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		$0 Sell
6
-37
-86% -$1.92K ﹤0.01% 2042
2022
Q1 		$3K Hold
43
– – ﹤0.01% 1694
2021
Q4 		$6K Sell
43
-8
-16% -$1.38K ﹤0.01% 1494
2021
Q3 		$11K Buy
51
+13
+34% +$2.87K ﹤0.01% 1306
2021
Q2 		$8K Sell
38
-16
-30% -$2.93K ﹤0.01% 1414
2021
Q1 		$10K Sell
54
-84
-61% -$16.7K ﹤0.01% 1295
2020
Q4 		$15K Buy
+138
New +$14.7K ﹤0.01% 1295

Other funds holding NVAX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Coatue Management
Coatue Management New York $48.6B AUM 94.27% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Voloridge Investment Management
Voloridge Investment Management Jupiter, Florida $23.5B AUM 33.24% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Private Capital Group's NVAX Position: Q2 2022 in Review

Private Capital Group reduced its Novavax (NVAX) stake by 86% in Q2 2022, selling an estimated $1.92K and leaving 6 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #2042.

Private Capital Group first reported a position in NVAX in Q4 2020 and has held it in 7 quarters since. The position peaked at $15K in Q4 2020. 325 funds tracked by Wall St. Rank hold NVAX as of Q2 2022.

  • Private Capital Group held 6 shares of Novavax worth $0 as of Q2 2022.
  • Private Capital Group sold 37 Novavax shares in Q2 2022, an estimated $1.92K.
  • Novavax made up ﹤0.01% of Private Capital Group's portfolio in Q2 2022, its #2042 holding.
  • Private Capital Group first reported a position in Novavax in Q4 2020 and has held it in 7 quarters since.
  • Private Capital Group's Novavax position peaked at $15K in Q4 2020.
  • 325 funds tracked by Wall St. Rank held Novavax as of Q2 2022.

Based on Private Capital Group's 13F filing for Q2 2022, filed 28 Jul 2022.